IMP3 expression in biopsy specimens as a diagnostic biomarker for colorectal cancer
- 1 June 2017
- journal article
- Published by Elsevier in Human Pathology
- Vol. 64, 137-144
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Mid-term oncologic outcome of a novel approach for locally advanced colon cancer with neoadjuvant chemotherapy and surgeryClinical and Translational Oncology, 2016
- Outcomes of preoperative chemoradiotherapy followed by surgery in patients with unresectable locally advanced sigmoid colon cancerChinese Journal of Cancer, 2016
- Advances in the management of colorectal cancer: from biology to treatmentInternational Journal of Colorectal Disease, 2014
- EURECCA colorectal: Multidisciplinary Mission statement on better care for patients with colon and rectal cancer in EuropeEuropean Journal of Cancer, 2013
- Predictors for underestimated pathology in forceps biopsy compared with resection specimen of colorectal neoplasia; focus on surface appearanceSurgical Endoscopy, 2013
- The feasibility and potential benefit of preoperative chemotherapy for colorectal liver metastasis (CLM): a single-centered retrospective studySurgery Today, 2012
- Feasibility of preoperative chemotherapy for locally advanced, operable colon cancer: the pilot phase of a randomised controlled trialThe Lancet Oncology, 2012
- Cancer screening in the United States, 2011CA: A Cancer Journal for Clinicians, 2011
- Detection of desmoplastic reaction in biopsy specimens is useful for predicting the depth of invasion of early colorectal cancer: a Japanese collaborative studyJournal of Gastroenterology, 2010
- Colorectal carcinoma in endoscopic biopsies; additional histologic criteria for the diagnosisPathology - Research and Practice, 2004